A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency
Clinical trial NCT01909479 · TERMINATED
Trial details
- NCT number
- NCT01909479
- Sponsor
- OPKO Health, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-08-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.